Nomograms for renal cell carcinoma

BJU International, Supplement

Volumn 95, Issue 2, 2005, Pages 14-15

  Marshall, Fray F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical variables; Nomogram; Prognosis; Renal cell carcinoma

Indexed keywords

CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONFERENCE PAPER; CYTOLOGY; EVALUATION; GRANULAR CELL TUMOR; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; NOMOGRAM; ONCOCYTOMA; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SYMPTOM; TUMOR VOLUME;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NOMOGRAMS; PROGNOSIS;

EID: 14644445990     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Zisman A, Pantuck AJ, Chao N et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cut-off point at 4.5 rather than 7 cm correlates better with clinical outcome. J Urol 2001; 166:54-8
2. Amin MB, Tamboli P, Javidan, et al. Prognostic impact of histological subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002; 26: 281-91
3. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63
4. Carducci MA, Piantadosi S, Pound CR et al. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. Urology 1999; 53: 44-9
5. Young AN, Amin MB, Moreno CS et al. Expression profiling of renall neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 2001; 158: 1639-51
6. Polascik TJ, Cairns P, Epstein JI et al. Distal nephron renal tumors: microsatellite allelotype. Cancer Res 1996; 56: 1892-5
7. Steiner G, Cairns P, Polascik TJ et al. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion of 1q32.1-32.2. Cancer Res 1996, 56: 5044-6
8. Brooks JD, Bova GS, Marshall FF, Isaacs WB. Tumor suppressor gene allelic loss in human renal cancers. J Urol 1993; 150: 1278-83
9. Paul R, Ewing CM, Robinson JC et al. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res 1997; 57: 2741-8
10. Elson PJ, Witte RS, Trump DL. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 1988; 48: 7310-3
11. Partin AW, Criley SR, Steiner MS et al. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 1995; 45: 211-7
12. O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 2002; 168: 1378-80
13. Zisman A, Pantuck AJ, Dorey F et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001; 19: 1649-57
14. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade, and necrosis: the SSIGN Score. J Urol 2002; 168: 2395-400
15. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166: 63-7